Cedilla Therapeutics
Cambridge
About Cedilla Therapeutics
Cedilla is a developer of therapeutics technologies intended to broaden the reach of small molecule therapeutics. The company's technology is focused on destabilizing oncoprotein targets that are also applicable to therapies outside of oncology, enabling doctors to treat diseases caused by protein dysregulation. The company was founded in 2018 and based in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $138.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2021)
- Website: cedillatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cedilla-therapeutics-87109 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.